# EDGAR Filing Document

**Accession Number:** 0001156375
**File Stem:** 0001156375-26-000016
**Filing Date:** 2026-4
**Character Count:** 34898
**Document Hash:** 72dbe124e46f8d06e985a6dd70533fc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001156375-26-000016.hdr.sgml**: 20260422

**ACCESSION NUMBER**: 0001156375-26-000016

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260422

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260422

**DATE AS OF CHANGE**: 20260422

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CME GROUP INC.
- **CENTRAL INDEX KEY:** 0001156375
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 364459170
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31553
- **FILM NUMBER:** 26881284

**BUSINESS ADDRESS:**
- **STREET 1:** 20 S. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 3129301000

**MAIL ADDRESS:**
- **STREET 1:** 20 S. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHICAGO MERCANTILE EXCHANGE HOLDINGS INC
- **DATE OF NAME CHANGE:** 20010802

?xml version='1.0' encoding='ASCII'? cme-20260422

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549** 

_________________________________________________________

**FORM 8-K** 

_________________________________________________________

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported) April 22, 2026** 

_________________________________________________________

**CME GROUP INC.** 

**(Exact Name of Registrant as Specified in its Charter)** 

_________________________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-31553** | **36-4459170** |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission<br>File No.)** | **(IRS Employer<br>Identification No.)** |

---

---

| | | | |
|:---|:---|:---|:---|
| **20 South Wacker Drive** | **Chicago** | **Illinois** | **60606** |
| **(Address of Principal Executive Offices)** | | | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (312) 930-1000** 

**N/A**

**(Former Name or Former Address, if Changed Since Last Report)** 

______________________________________________________

**Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (***see* **General Instruction A.2. below):**

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

<u>☐</u> <u>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</u>

Securities registered pursuant to Section 12(b) of the Act:

<u>Title of each class</u> <u>Trading symbol</u> <u>Name of each exchange on which registered</u> <br> Class A Common Stock CME Nasdaq

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

------

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 2.02.** | **Results of Operations and Financial Condition.** |

---

The information set forth under "Item 2.02. Results Of Operations and Financial Condition," including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated April 22, 2026, reporting CME Group Inc.'s financial results for the quarter ended March 31, 2026.

To supplement CME Group's financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.'s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company's prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description** |
| 99.1 | <u>[Press Release, dated](exhibit9913312026.htm)[April](exhibit9913312026.htm)[22, 202](exhibit9913312026.htm)[6](exhibit9913312026.htm)[.](exhibit9913312026.htm)</u> |
| 104 | The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **CME Group Inc.** | **CME Group Inc.** |
| | Registrant | Registrant |
| Date: April 22, 2026 | By: | /s/ Lynne Fitzpatrick |
|  | Name:<br>Title: | **Lynne Fitzpatrick<br>Senior Managing Director, President and Chief Financial Officer<br>Principal Financial Offer and<br>Duly Authorized Officer** |
|  |  | **Lynne Fitzpatrick<br>Senior Managing Director, President and Chief Financial Officer<br>Principal Financial Offer and<br>Duly Authorized Officer** |

---

## Exhibit 99.1

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibit 99.1**

![cmeglogoa.jpg](cmeglogoa.jpg)

---

| | |
|:---|:---|
| **Media contact** | **Investor contact** |
| Timothy Barello, 212.299.2256 | Adam Minick, 312.340.8365 |
| Laurie Bischel, 312.648.8698 | <u>investors@cmegroup.com</u> |
| <u>news@cmegroup.com</u> | CME-G |
| <u>cmegroup.mediaroom.com</u> | |

---

**<u>FOR IMMEDIATE RELEASE</u>**

**CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Record revenue of $1.9 billion, up 14%**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Net income and diluted earnings per share both up 20%**

CHICAGO, April 22, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the first quarter of 2026.

The company reported revenue of $1.9 billion and operating income of $1.3 billion for the first quarter of 2026. Net income was $1.2 billion and diluted earnings per common share were $3.18. On an adjusted basis, operating income was $1.4 billion, net income was $1.2 billion and diluted earnings per common share were $3.36. Financial results presented on an adjusted basis for the first quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.<sup>1</sup>&nbsp;&nbsp;&nbsp;&nbsp;

"In a world in which risk has become the new normal, 2026 is off to a record-breaking start as clients around the world turn to CME Group's trusted, regulated markets to hedge across asset classes and in all trading environments," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Robust demand for our products drove Q1 average daily volume up 22% to a record 36.2 million contracts, including records in all six asset classes. This exceptional market participation translated directly into record financial performance, with revenue rising 14% and adjusted net income and diluted EPS increasing 20%. Efficiencies provided to our client base also hit a new high in Q1 with over $85 billion in average daily margin savings, and we're very pleased to further extend our FICC cross-margining agreement to end-user clients later this month. Looking ahead, innovation remains central to our growth strategy. We will continue to work closely with our clients as we expand the range of products and services we provide to help them manage risk and pursue opportunities in a rapidly evolving marketplace."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Diluted Earnings per Common Share charts at the end of the financial statements.**

**- more -** 

------

**Page 2**

First-quarter 2026 average daily volume (ADV) reached a quarterly all-time high of 36.2 million contracts, up 22% from first-quarter 2025. Non-U.S. ADV was a record 11.4 million contracts, up 30% compared with the same period in 2025, including the highest quarterly ADV across all regions, with APAC up 33% and EMEA up 29%.

Clearing and transaction fees revenue for first-quarter 2026 totaled a record $1.5 billion. The total average rate per contract was $0.652. Market data revenue totaled a record $224 million for first-quarter 2026.

As of March 31, 2026, the company had $2.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the first quarter of approximately $2.7 billion and repurchased $536 million in CME Group common shares.

**CME Group will hold a Q&A conference call to discuss first-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at** <u>investor.cmegroup.com</u> **under Events & Presentations. An archived recording will be available for up to two months after the call.**

As the world's leading derivatives marketplace, CME Group (<u>www.cmegroup.com</u>) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on <u>interest rates</u>, <u>equity indexes</u>, <u>foreign exchange</u>, <u>cryptocurrencies</u>, <u>energy</u>, <u>agricultural products</u> and <u>metals</u>. The company offers futures and options on futures trading through the <u>CME Globex</u> platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

**- more -**

------

**Page 3**

*Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on* 

------

*futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".*

\# \# \#

------

**CME Group Inc. and Subsidiaries**

**Consolidated Balance Sheets**

(in millions)

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| ASSETS |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2391.2 | $4416.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marketable securities | 124.2 | 125.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance | 935.5 | 639.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets (includes $6.4 and $6.5 in restricted cash) | 515.0 | 522.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance bonds and guaranty fund contributions | 165035.3 | 159656.1 |
| Total current assets | 169001.2 | 165359.3 |
| Property, net of accumulated depreciation and amortization | 355.4 | 362.7 |
| Intangible assets—trading products | 17175.3 | 17175.3 |
| Intangible assets—other, net | 2550.8 | 2610.7 |
| Goodwill | 10506.0 | 10514.7 |
| Other assets | 2404.8 | 2401.5 |
| Total Assets | $201993.5 | $198424.2 |
| LIABILITIES AND EQUITY |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $75.4 | $71.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 887.1 | 568.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance bonds and guaranty fund contributions | 165035.3 | 159656.1 |
| Total current liabilities | 165997.8 | 160296.7 |
| Long-term debt | 3423.2 | 3422.3 |
| Deferred income tax liabilities, net | 5221.1 | 5242.2 |
| Other liabilities | 733.2 | 734.8 |
| Total Liabilities | 175375.3 | 169696.0 |
| Total CME Group Shareholders' Equity | 26618.2 | 28728.2 |
| Total Liabilities and Equity | $201993.5 | $198424.2 |

---

------

**CME Group Inc. and Subsidiaries**

**Consolidated Statements of Income**

(dollars in millions, except per share amounts; shares in thousands)

---

| | | |
|:---|:---|:---|
| | **Quarter Ended<br> March 31,** | **Quarter Ended<br> March 31,** |
| | **2026** | **2025** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clearing and transaction fees | $1542.6 | $1337.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Market data and information services | 224.1 | 194.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 113.4 | 110.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Revenues** | 1880.1 | 1642.3 |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits | 223.0 | 206.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technology | 76.6 | 65.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional fees and outside services | 28.2 | 28.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of purchased intangibles | 56.1 | 55.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 27.2 | 27.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Licensing and other fee agreements | 106.8 | 96.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 52.5 | 54.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Expenses** | 570.4 | 534.3 |
| **Operating Income** | 1309.7 | 1108.0 |
| **Non-Operating Income (Expense)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment income | 1389.3 | 892.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other borrowing costs | (43.6) | (41.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of unconsolidated subsidiaries | 102.4 | 88.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-operating income (expense) | (1246.9) | (802.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Non-Operating Income (Expense)** | 201.2 | 136.8 |
| **Income before Income Taxes** | 1510.9 | 1244.8 |
| Income tax provision | 356.6 | 288.6 |
| **Net Income** | $1154.3 | $956.2 |
| **Net Income Attributable to Common Shareholders of CME Group - Basic**<sup>(1)</sup> | $1168.0 | $944.2 |
| **Net Income Attributable to Common Shareholders of CME Group - Diluted**<sup>(1)</sup> | $1154.3 | $944.2 |
| **Earnings per Share Attributable to Common Shareholders of CME Group:** |  |  |
| Basic | $3.25 | $2.63 |
| Diluted | 3.18 | 2.62 |
| **Weighted Average Number of Common Shares:** |  |  |
| Basic | 359318 | 359613 |
| Diluted<sup>(2)</sup> | 363208 | 360227 |
| 1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. | 1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. | 1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. |
| 2. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. | 2. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. | 2. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. |

---

------

---

| | | |
|:---|:---|:---|
| **CME Group Inc. and Subsidiaries** | **CME Group Inc. and Subsidiaries** | **CME Group Inc. and Subsidiaries** |
| **Reconciliation of Adjusted Operating Income** | **Reconciliation of Adjusted Operating Income** | **Reconciliation of Adjusted Operating Income** |
| (dollars in millions) | (dollars in millions) | (dollars in millions) |
|  | **Quarter Ended<br> March 31,** | **Quarter Ended<br> March 31,** |
|  | **2026** | **2025** |
| **Total Revenues** | $1880.1 | $1642.3 |
| **Adjusted Total Revenues** | $1880.1 | $1642.3 |
| **Total Expenses** | $570.4 | $534.3 |
| Restructuring and severance | (4.0) | (1.1) |
| Deferred compensation<sup>(1)</sup> | 0.8 | 2.2 |
| Amortization of purchased intangibles | (56.1) | (55.2) |
| Strategic transaction-related (costs) credits | (0.6) |  |
| Real estate-related (costs) credits | (0.7) |  |
| Foreign exchange transaction gains (losses) | 0.9 | (2.3) |
| Litigation matters or settlements | 1.0 | (3.3) |
| **Adjusted Total Expenses** | $511.7 | $474.6 |
| **Operating Income** | $1309.7 | $1108 |
| **Adjusted Operating Income** | $1368.4 | $1167.7 |
| 1. Includes $0.8 million for a change in our non-qualified deferred compensation liability in the first quarter of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income. | 1. Includes $0.8 million for a change in our non-qualified deferred compensation liability in the first quarter of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income. | 1. Includes $0.8 million for a change in our non-qualified deferred compensation liability in the first quarter of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income. |

---

------

---

| | | |
|:---|:---|:---|
| **CME Group Inc. and Subsidiaries** | **CME Group Inc. and Subsidiaries** | **CME Group Inc. and Subsidiaries** |
| **Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share** | **Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share** | **Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share** |
| (dollars in millions, except per share amounts; shares in thousands) | (dollars in millions, except per share amounts; shares in thousands) | (dollars in millions, except per share amounts; shares in thousands) |
|  | **Quarter Ended<br> March 31,** | **Quarter Ended<br> March 31,** |
|  | **2026** | **2025** |
| **Net Income** | $1154.3 | $956.2 |
| Restructuring and severance | 4.0 | 1.1 |
| Amortization of purchased intangibles<sup>(1)</sup> | 60.1 | 68.2 |
| Strategic transaction-related costs (credits)<sup>(2)</sup> | 0.1 |  |
| Real estate-related costs (credits) | 0.7 |  |
| Foreign exchange transaction (gains) losses | (0.9) | 2.3 |
| Unrealized and realized (gains) losses on investments | 22.9 | 6.5 |
| Litigation matters or settlements | (1.0) | 3.3 |
| Income tax effect related to above | (21.0) | (16.1) |
| Other income tax items | 0.9 | (1.6) |
| **Adjusted Net Income** | $1220.1 | $1019.9 |
| **Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic**<sup>(3)</sup> | $1233.2 | $1007.1 |
| **Adjusted Net Income Attributable to Common Shareholders of CME Group - Diluted**<sup>(3)</sup> | $1220.1 | $1007.1 |
| **Earnings per Share Attributable to Common Shareholders of CME Group:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | $3.25 | $2.63 |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | 3.18 | 2.62 |
| **Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | $3.43 | $2.80 |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted | 3.36 | 2.80 |
| **Weighted Average Number of Common Shares:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Basic | 359318 | 359613 |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted<sup>(4)</sup> | 363208 | 360227 |
| 1. Includes $2.6 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the first quarter of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income. | 1. Includes $2.6 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the first quarter of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income. | 1. Includes $2.6 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the first quarter of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income. |
| 2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as<br>that schedule does not include adjustment items or portions of items included in non-operating results. | 2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as<br>that schedule does not include adjustment items or portions of items included in non-operating results. | 2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as<br>that schedule does not include adjustment items or portions of items included in non-operating results. |
| 3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. | 3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. | 3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares. |
| 4. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. | 4. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. | 4. Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026. |

---

------

**CME Group Inc. and Subsidiaries**

**Quarterly Operating Statistics**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **1Q 2025** | **2Q 2025** | **3Q 2025** | **4Q 2025** | **1Q 2026** |
| **Trading Days** | 61 | 62 | 64 | 64 | 61 |

---

**Quarterly Average Daily Volume (ADV)**<sup>(1)</sup>

**CME Group ADV (in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Product Line** | **1Q 2025** | **2Q 2025** | **3Q 2025** | **4Q 2025** | **1Q 2026** |
| Interest rates | 15029 | 15472 | 13378 | 13010 | 18674 |
| Equity indexes | 7997 | 7661 | 6278 | 7738 | 8655 |
| Foreign exchange | 1149 | 1096 | 834 | 853 | 1193 |
| Energy | 2903 | 3082 | 2295 | 2523 | 3985 |
| Agricultural commodities | 1958 | 1964 | 1712 | 1787 | 2042 |
| Metals | 732 | 943 | 825 | 1441 | 1682 |
| **Total** | 29768 | 30217 | 25322 | 27353 | 36231 |
| **<u>Venue</u>** |  |  |  |  |  |
| CME Globex | 27732 | 28097 | 23418 | 25542 | 33633 |
| Open outcry | 881 | 993 | 989 | 816 | 1241 |
| Privately negotiated | 1154 | 1127 | 915 | 995 | 1357 |
| **Total** | 29768 | 30217 | 25322 | 27353 | 36231 |

---

**Quarterly Average Rate Per Contract (RPC)**<sup>(1)</sup>

**CME Group RPC**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Product Line** | **1Q 2025** | **2Q 2025** | **3Q 2025** | **4Q 2025** | **1Q 2026** |
| Interest rates | $0.476 | $0.481 | $0.487 | $0.486 | $0.457 |
| Equity indexes | 0.624 | 0.635 | 0.652 | 0.611 | 0.597 |
| Foreign exchange | 0.762 | 0.772 | 0.841 | 0.847 | 0.780 |
| Energy | 1.222 | 1.138 | 1.214 | 1.245 | 1.084 |
| Agricultural commodities | 1.376 | 1.435 | 1.423 | 1.427 | 1.344 |
| Metals | 1.588 | 1.456 | 1.505 | 1.295 | 1.153 |
| Average RPC | $0.686 | $0.690 | $0.702 | $0.707 | $0.652 |
| 1. ADV and RPC includes futures and options on futures only. | 1. ADV and RPC includes futures and options on futures only. | 1. ADV and RPC includes futures and options on futures only. | 1. ADV and RPC includes futures and options on futures only. | 1. ADV and RPC includes futures and options on futures only. |  |

---

<br>